What changed
Adjusted EPS of $1.90 topped the $1.88 consensus by $0.02 (+1.0%), though it was flat YoY. Revenue came in at $2.063B, up 3.1% reported and 3.7% constant currency, with management raising FY2026 adjusted EPS guidance to $8.50-$8.60 and tightening reported revenue growth to 4.4%-4.9%. The top line was powered by broad-based strength in Hips (+6.0% reported, +7.0% cc), S.E.T. (+6.8% reported, +7.1% cc) and Technology & Data, Bone Cement and Surgical (+11.9% reported, +13.0% cc), offsetting a 3.1% reported decline in Knees.
Why it matters
Adjusted EPS of $1.90 topped the $1.88 consensus by $0.02 (+1.0%), though it was flat YoY. Revenue came in at $2.063B, up 3.1% reported and 3.7% constant currency, with management raising FY2026 adjus